Jamjoom Pharmaceuticals Factory Dividends and Buybacks
Dividend criteria checks 3/6
Jamjoom Pharmaceuticals Factory is a dividend paying company with a current yield of 2.06% that is well covered by earnings.
Key information
2.1%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 2.7% |
| Dividend Growth | 14.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ر.س3.200 |
| Payout ratio | 62% |
Recent dividend and buyback updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 4015's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 4015's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Jamjoom Pharmaceuticals Factory Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4015) | 2.1% |
| Market Bottom 25% (SA) | 1.8% |
| Market Top 25% (SA) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (4015) (up to 3 years) | 2.7% |
Notable Dividend: 4015's dividend (2.06%) is higher than the bottom 25% of dividend payers in the SA market (1.83%).
High Dividend: 4015's dividend (2.06%) is low compared to the top 25% of dividend payers in the SA market (4.79%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (62.1%), 4015's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (88%), 4015's dividend payments are covered by cash flows.